st. gallen consensus highlights: ovarian suppression, oligometastatic disease and radiotherapy
Published 3 years ago • 166 plays • Length 5:34Download video MP4
Download video MP3
Similar videos
-
16:13
systemic therapy at the st gallen consensus: multi-gene testing, ki67, and oligometastatic disease
-
10:02
the st. gallen consensus session: loco-regional treatment
-
3:10
highlights from the st. gallen consensus panel
-
3:11
st. gallen consensus 2021: neoadjuvant and adjuvant therapy for her2 breast cancer
-
2:41
key updates from the st gallen consensus session
-
4:00
key takeaways from the st. gallen consensus panel
-
1:45
key topics at st. gallen 2021
-
0:43
st gallen bcc 2023 highlights
-
1:23
st. gallen international consensus on the optimal primary treatment of women with breast cancer
-
4:47
breast reconstruction and radiation therapy consensus from airo
-
1:36
st. gallen bcc 2023 highlights
-
1:37
consolidative radiotherapy for oligometastatic her2-negative esophageal and gastric adenocarcinoma.
-
0:57
highlights from st. gallen bcc 2023
-
0:54
de-escalation of radiation therapy after primary systemic therapy in non-metastatic breast cancer
-
25:31
clinical science forum: "oligometastatic disease: definitions and practice patterns"
-
1:07
hereditary breast cancer at st. gallen bcc 2023
-
1:54
hot topics at st gallen bcc
-
1:08
st gallen 2023: de-escalation, personalized treatment & adjuvant io following neoadjuvant io
-
2:19
5-year dmfs outcomes in the nbreast ii trial